dc.contributorUniversidade Estadual de Maringá (UEM)
dc.contributorInstituto Adolfo Lutz (IAL)
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorUniversidade de São Paulo (USP)
dc.date.accessioned2014-05-20T13:24:17Z
dc.date.available2014-05-20T13:24:17Z
dc.date.created2014-05-20T13:24:17Z
dc.date.issued2011-05-01
dc.identifierJournal of Antimicrobial Chemotherapy. Oxford: Oxford Univ Press, v. 66, n. 5, p. 1044-1046, 2011.
dc.identifier0305-7453
dc.identifierhttp://hdl.handle.net/11449/7488
dc.identifier10.1093/jac/dkr057
dc.identifierWOS:000289584000014
dc.identifier2114570774349859
dc.description.abstractObjectives: The resazurin microtitre plate assay (REMA) was evaluated to determine the susceptibility of Mycobacterium tuberculosis to pyrazinamide, and was compared with the broth microdilution method (BMM), the absolute concentration method (ACM) and pyrazinamidase (PZase) determination.Methods: Thirty-four M. tuberculosis clinical isolates (26 susceptible and 8 resistant to pyrazinamide) and reference strains M. tuberculosis H37Rv ATCC 27294 and Mycobacterium bovis AN5 were tested.Results: REMA and BMM showed 100% specificity and sensitivity when compared with ACM; BMM, however, demanded more reading time. The PZase determination assay showed 87.50% and 100% sensitivity and specificity, respectively.Conclusions: All tested methods in this preliminary study showed excellent sensitivity and specificity for the determination of pyrazinamide susceptibility of M. tuberculosis, but REMA was faster, low-cost and easy to perform and interpret. Additional studies evaluating REMA for differentiating pyrazinamide-resistant and-susceptible M. tuberculosis should be conducted on an extended panel of clinical isolates.
dc.languageeng
dc.publisherOxford University Press
dc.relationJournal of Antimicrobial Chemotherapy
dc.relation5.217
dc.relation2,419
dc.rightsAcesso restrito
dc.sourceWeb of Science
dc.subjectTB
dc.subjectmycobacteria
dc.subjectsusceptibility testing
dc.titleRapid detection of resistance to pyrazinamide in Mycobacterium tuberculosis using the resazurin microtitre assay
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución